Bulletin
Diverging decisions on inventive step: UPC revokes Sanofi’s Cabazitaxel second medical use patent maintained by EPO
Subscribe to our insights here so you can keep on top of the latest IP developments and updates.
Diverging decisions on inventive step: UPC revokes Sanofi’s Cabazitaxel second medical use patent maintained by EPO
Dryrobe avoids “genericide” in High Court decision
How The Grinch won Christmas: character merchandising and IP in Christmas adverts
WIPO announces key updates to the 13th edition of the nice classification system
No ifs, just butts – another slogan dispute for Sweaty Betty
Recording assignments of IP rights worldwide: procedures and pitfalls
A bad beginning makes a bad ending
Success at the UPC
When is a rose not a rose? When it’s a tyre: the first smell trade mark accepted for advertisement in India
Dr Michelle Pratt in conversation with Anna Elagina, Finance Director
Can a celebrity register a trade mark for their face in the UK to combat AI deepfakes?
UPC Court of Appeal overturns revocation of Amgen’s PCSK9 antibody patent and clarifies the UPC’s inventive step approach (Amgen v Sanofi and Regeneron)
“Wear the damn shorts” – Sweaty Betty and the tricky question of ownership in slogans
No one-size-fits-all: Unitary patent or national validation?
Clarity of dependent claims and consequences for amendments in opposition proceedings
Stay alert: misleading trade mark communications on the rise
Insufficiency arising from a partially incompatible dependent claim
Killer bars?
A ‘holistic’ approach to inventive step
Use it or risk losing it: Upcoming changes facing owners of comparable UK trade marks
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
Once again Boult is recognised as Tier 1 for both patents and trade marks in the Legal 500 UK rankings for 2026.
Boult has earned a Silver Medal from EcoVadis, the global sustainability ratings platform - recognising our commitment to ethical, responsible and environmentally conscious business practices.
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
Once again Boult is recognised as Tier 1 for both patents and trade marks in the Legal 500 UK rankings for 2026.
Boult has earned a Silver Medal from EcoVadis, the global sustainability ratings platform - recognising our commitment to ethical, responsible and environmentally conscious business practices.